Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.

A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV/HIV-1 coinfected patients.

Shen T, Chen X, Zhang W, Xi Y, Cao G, Zhi Y, Wang S, Xu C, Wei L, Lu F, Zhuang H.

PLoS One. 2011;6(8):e23550. doi: 10.1371/journal.pone.0023550. Epub 2011 Aug 12.

2.

Effectiveness of HCV core antigen and RNA quantification in HCV-infected and HCV/HIV-1-coinfected patients.

Long L, Shen T, Gao J, Duan Z, Liang H, Lu F.

BMC Infect Dis. 2014 Nov 5;14:577. doi: 10.1186/s12879-014-0577-1.

3.

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.

Rallón NI, Soriano V, Restrepo C, García-Samaniego J, Labarga P, López M, Peris A, González-Lahoz J, Benito JM.

J Acquir Immune Defic Syndr. 2011 May 1;57(1):1-8.

PMID:
21786458
4.

Effect of coexisting HIV-1 infection on the diagnosis and evaluation of hepatitis C virus.

Bonacini M, Lin HJ, Hollinger FB.

J Acquir Immune Defic Syndr. 2001 Apr 1;26(4):340-4.

PMID:
11317075
5.

[A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].

Long L, Liu Y, Duan Z, Xu Q, Shen T, Dou X, Zhuang H, Lu F.

Zhonghua Gan Zang Bing Za Zhi. 2014 Apr;22(4):244-50. doi: 10.3760/cma.j.issn.1007-3418.2014.04.002. Chinese.

PMID:
25173220
6.

Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.

Kang F, Chen W, Zhang X, Nie W, Fu J, Xu X, Zhao P, Zhang X, Li W, Wang FS, Zhang Z, Zhao M.

J Acquir Immune Defic Syndr. 2013 Feb 1;62(2):135-42. doi: 10.1097/QAI.0b013e3182752d20.

PMID:
23075912
7.

Higher dN/dS ratios in the HCV core gene, but not in the E1/HVR1 gene, are associated with human immunodeficiency virus-associated immunosuppression.

Xu CH, Shen T, Zheng JJ, Tu J, Zhang WD, Lu FM.

Arch Virol. 2012 Nov;157(11):2153-62. doi: 10.1007/s00705-012-1390-z. Epub 2012 Jul 24.

PMID:
22825695
8.

Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.

Dong Y, Qiu C, Xia X, Wang J, Zhang H, Zhang X, Xu J.

Arch Virol. 2015 Apr;160(4):929-36. doi: 10.1007/s00705-014-2311-0. Epub 2015 Jan 24.

PMID:
25616842
9.

Hepatitis C plasma viral load is associated with HCV genotype but not with HIV coinfection.

Berger A, von Depka Prondzinski M, Doerr HW, Rabenau H, Weber B.

J Med Virol. 1996 Apr;48(4):339-43.

PMID:
8699166
10.

Stronger hepatitis C virus-specific CD8+ T-cell responses in HIV coinfection.

Barrett L, Gallant M, Howley C, Ian Bowmer M, Hirsch G, Peltekian K, Grant M.

J Viral Hepat. 2011 Mar;18(3):170-80. doi: 10.1111/j.1365-2893.2010.01293.x.

PMID:
20497309
11.

Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China.

Zhang T, Tully DC, Zhou S, He N.

PLoS One. 2014 Apr 7;9(4):e94219. doi: 10.1371/journal.pone.0094219. eCollection 2014.

12.

Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.

Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G.

J Viral Hepat. 2007 Nov;14(11):806-11.

PMID:
17927617
13.

The magnitude and breadth of hepatitis C virus-specific CD8+ T cells depend on absolute CD4+ T-cell count in individuals coinfected with HIV-1.

Kim AY, Lauer GM, Ouchi K, Addo MM, Lucas M, Schulze Zur Wiesch J, Timm J, Boczanowski M, Duncan JE, Wurcel AG, Casson D, Chung RT, Draenert R, Klenerman P, Walker BD.

Blood. 2005 Feb 1;105(3):1170-8. Epub 2004 Sep 30.

14.

HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.

MacParland SA, Fadel SM, Mihajlovic V, Fawaz A, Kim C, Rahman AK, Liu J, Kaul R, Kovacs C, Grebely J, Dore GJ, Wong DK, Ostrowski MA.

PLoS One. 2016 Apr 28;11(4):e0154433. doi: 10.1371/journal.pone.0154433. eCollection 2016.

15.
16.

Circulating viral core and E1 antigen levels as supplemental markers for HCV chronic hepatitis.

El Awady MK, El Abd YS, Shoeb HA, Tabll AA, Hosny Ael D, El Shenawy RM, Atef K, Bader El Din NG, Bahgat MM.

Virol J. 2006 Sep 1;3:67.

17.

HCV core antigen testing in HIV- and HBV-coinfected patients, and in HCV-infected patients on hemodialysis.

Mederacke I, Potthoff A, Meyer-Olson D, Meier M, Raupach R, Manns MP, Wedemeyer H, Tillmann HL.

J Clin Virol. 2012 Feb;53(2):110-5. doi: 10.1016/j.jcv.2011.11.009. Epub 2011 Dec 15.

PMID:
22177274
18.

The correlation between hepatitis C core antigen and hepatitis C virus RNA levels with respect to human immunodeficiency virus status, hepatitis C virus genotype and interferon-lambda-4 polymorphism.

Thong VD, Akkarathamrongsin S, Avihingsanon A, Theamboonlers A, Poovorawan Y, Tangkijvanich P.

Intervirology. 2015;58(2):73-9. doi: 10.1159/000370070. Epub 2015 Feb 13.

PMID:
25677196
20.

Supplemental Content

Support Center